Rep. Norm Thurston — Voting Record

Utah House District 62 · complete roll-call record from le.utah.gov
← All votes

Bill

Drug Distribution Amendments
Number
H.B. 356 (2026GS)
Sponsor
Rep. Monson, Logan
Final action
Governor Signed 2/27/2026
Outcome
Became law — signed by Gov. Spencer J. Cox

Summary

This bill amends provisions related to the 340B drug discount program.

What it does

  • This bill:
  • defines a 340B covered entity and a 340B eligible drug;
  • clarifies prohibited actions under the 340B drug discount program;
  • defines terms; and
  • makes technical and conforming changes.

Every vote on this bill

2026-01-30House Comm - Favorable Recommendation
House Health and Human Services Committee
11-0-3not eligible / no record
2026-01-30House Comm - Consent Calendar Recommendation
House Health and Human Services Committee
11-0-3not eligible / no record
2026-02-12Senate Comm - Favorable Recommendation
Senate Health and Human Services Committee
5-0-2not eligible / no record
2026-02-04House/ passed 3rd reading
Senate Secretary
70-0-5YEA
2026-02-18Senate/ passed 2nd reading
Senate 3rd Reading Calendar
21-0-8not eligible / no record
2026-02-19Senate/ passed 3rd reading
Senate President
25-0-4not eligible / no record

Bill text

enrolled version · official source
15
31A-46-311
0
Drug Distribution Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Logan J. Monson
Senate Sponsor: Evan J. Vickers
LONG TITLE
General Description:
This bill amends provisions related to the 340B drug discount program.
Highlighted Provisions:
This bill:
defines a 340B covered entity and a 340B eligible drug;
clarifies prohibited actions under the 340B drug discount program;
defines terms; and
makes technical and conforming changes.
Money Appropriated in this Bill:
None
Other Special Clauses:
This bill provides a special effective date.
Utah Code Sections Affected:
AMENDS:
31A-46-311
, as enacted by Laws of Utah 2025, Chapter 514
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
31A-46-311
 is amended to read:
31A-46-311
. Prohibited actions with respect to the 340B drug discount program.
(1)
As used in this section
,
:
(a)
"340B covered entity" means the same as the term "covered entity" is defined in 42 
U.S.C. Sec. 256b(a)(4).
(b)
"340B eligible drug" means a drug purchased through the 340B drug discount 
program, in accordance with 42 U.S.C. Sec. 256b, by a 340B covered entity.
(c)
"Contracted pharmacy" means a pharmacy contracting with a 340B covered entity to 
dispense 340B eligible drugs.
(d)
"manufacturer"
"Manufacturer"
 means a pharmaceutical manufacturer, including an 
agent or affiliate of a pharmaceutical manufacturer.
(e)
"Pharmacy" means any place where drugs are dispensed.
(2)
A manufacturer may not:
(a)
directly or indirectly restrict or prohibit:
(i)
a pharmacy from contracting with a 340B 
covered 
entity, including by denying the 
pharmacy access to a drug that is manufactured by the manufacturer;
(ii)
a 340B 
covered 
entity from contracting with a pharmacy, including by denying 
the 340B 
covered 
entity access to a drug that is manufactured by the manufacturer;
(iii)
the acquisition, dispensing, or delivery of a 340B 
eligible 
drug to any location 
authorized by a 340B 
covered 
entity to receive the drug, unless prohibited by 
federal law; or
(iv)
a 340B 
covered 
entity from receiving 
340B drug discount program pricing for 
a 
340B 
eligible 
drug, including by imposing a time limitation on a 340B 
covered 
entity to replenish or submit a claim for a 340B 
eligible 
drug;
(b)
directly or indirectly:
(i)
require a 340B 
covered 
entity to purchase a 340B 
eligible 
drug from a supplier if 
the manufacturer would otherwise permit the 340B 
covered 
entity to purchase a 
drug that is not a 340B 
eligible 
drug from the supplier; or
(ii)
require a 340B 
covered 
entity
 or a contracted pharmacy
 to submit any claim data, 
utilization data, or information about a 340B 
covered 
entity's contracts with a 
third-party
, unless the data or information sharing is required by federal law,
 as a 
condition for allowing
:
(A)
the acquisition of a 340B 
eligible 
drug by
,
 a 340B covered entity;
 or 
(B)
delivery of a 340B 
eligible 
drug to
,
 a 340B 
covered 
entity
, unless the data 
or information sharing is required by federal law
 or a contracted pharmacy
; or
(c)
interfere with:
(i)
a contract between a pharmacy and a 340B 
covered 
entity; or
(ii)
the ability of a pharmacy and a 340B 
covered 
entity to enter into a contract.
(3)
The Public Employees' Benefit and Insurance Program created in Section 
49-20-103
may adjust the program's business practices to mitigate any financial impacts resulting 
from this section.
(4)
Nothing in this section is to be construed to conflict with federal law.
Section 2. 
Effective Date.
This bill takes effect:
(1)
except as provided in Subsection (2), 
May 6, 2026
; or
(2)
if approved by two-thirds of all members elected to each house:
(a)
upon approval by the governor;
(b)
without the governor's signature, the day following the constitutional time limit of 
Utah Constitution, Article VII, Section 8; or
(c)
in the case of a veto, the date of veto override.
1-23-26 11:47 AM